Sphere Medical Holding PLC

LSE:SPHR (UK)  
£ 0.00 (-15.79%) Sep 19
At Loss
P/B:
0.17
Market Cap:
£ 567.00K ($ 722.00K)
Enterprise V:
£ -2.67M ($ -3.41M)
Volume:
4.87M
Avg Vol (2M):
2.01M
Volume:
4.87M
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sphere Medical Holding PLC ( ) from 2011 to Jun 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sphere Medical Holding PLC stock (LSE:SPHR) PE ratio as of Jun 11 2024 is 0. More Details

Sphere Medical Holding PLC (LSE:SPHR) PE Ratio (TTM) Chart

To

Sphere Medical Holding PLC (LSE:SPHR) PE Ratio (TTM) Historical Data

Total 0
  • 1
Sphere Medical Holding PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Sphere Medical Holding PLC (LSE:SPHR) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.